Cargando…

Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report

BACKGROUND: Autoimmune encephalitis (AE) is a newly recognized autoimmune disorders in which the targets are proteins or receptors involved in synaptic transmission and neuronal excitability. α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a subtype of glutamate receptor tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Qingyang, Wu, Xianghong, Huang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563362/ https://www.ncbi.nlm.nih.gov/pubmed/31195997 http://dx.doi.org/10.1186/s12883-019-1358-7

Ejemplares similares

Fulminant anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR1 antibodies encephalitis in a Chinese boy: a case report
por: Han, Wei, et al.
Publicado: (2022)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: A case report
por: Yang, Jing, et al.
Publicado: (2021)

Thoracoscopic thymectomy for juvenile myasthenia gravis
por: Kim, Aimee G., et al.
Publicado: (2019)

Subxiphoid thoracoscopic thymectomy for myasthenia gravis
por: Liu, Yuanyuan, et al.
Publicado: (2021)

Subxiphoid completion thymectomy for refractory non-thymomatous myasthenia gravis
por: Ambrogi, Vincenzo, et al.
Publicado: (2020)

Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review
por: Zhang, Tian-Yi, et al.
Publicado: (2021)

Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis
por: Zhang, Zhe, et al.
Publicado: (2021)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

Thymectomy in Myasthenia Gravis: A Narrative Review
por: Aljaafari, Danah, et al.
Publicado: (2022)

Cellular Plasticity Induced by Anti–α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Receptor Encephalitis Antibodies
por: Peng, Xiaoyu, et al.
Publicado: (2015)

Complete Remission of Generalized Myasthenia Gravis by Corticosteroid Treatment Alone without Thymectomy
por: Kataoka, Hiroshi, et al.
Publicado: (2011)

Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011)

Robotic thymectomy for myasthenia gravis surgical techniques and outcomes
por: Raza, Beebarg, et al.
Publicado: (2021)

Outcomes after Thymectomy in Patients with Thymomatous Myasthenia Gravis
por: Rabiou, Sani, et al.
Publicado: (2022)

Outcomes after thymectomy in non-thymomatous myasthenia gravis
por: Deboever, Nathaniel, et al.
Publicado: (2023)

Anesthesia for patients undergoing transsternal thymectomy for juvenile myasthenia gravis
por: Stephenson, Lianne, et al.
Publicado: (2011)

Post-thymectomy myasthenia gravis with an episode of Osserman stage III
por: Kuwata, T, et al.
Publicado: (2012)

Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis
por: Cataneo, Antônio J. M., et al.
Publicado: (2018)

Thoracoscopic Thymectomy for Myasthenia Gravis: Seven Years of Clinical Experience
por: Daneshvar Kakhaki, Abolghasem, et al.
Publicado: (2016)

Early extubation after thymectomy is good for the patients with myasthenia gravis
por: Chen, Li, et al.
Publicado: (2019)

Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy
por: Alqarni, Fatmah, et al.
Publicado: (2021)

Robotic-assisted minimally invasive thymectomy for myasthenia gravis with thymoma
por: Su, Katherine W., et al.
Publicado: (2022)

Thymectomy in myasthenia gravis: “The real world” experience beyond studies
por: Waheed, Waqar, et al.
Publicado: (2022)

Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis
por: Zhang, Jinwei, et al.
Publicado: (2022)

Transareolar uniportal thoracoscopic extended thymectomy for patients with myasthenia gravis
por: Lin, Jianbo, et al.
Publicado: (2022)

Two Unique Cases with Anti-GluR Antibody-Positive Encephalitis
por: Matsuzono, Kosuke, et al.
Publicado: (2013)

GluA1 subunit ubiquitination mediates amyloid-β-induced loss of surface α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
por: Guntupalli, Sumasri, et al.
Publicado: (2017)

Resolution of Autoimmune Oophoritis after Thymectomy in a Myasthenia Gravis Patient
por: Çakır, Esra Deniz Papatya, et al.
Publicado: (2011)

Intravenous flurbiprofen for post-thymectomy pain relief in patients with myasthenia gravis
por: Su, Chunhua, et al.
Publicado: (2012)

Value of Adjuvant Radiotherapy for Thymoma with Myasthenia Gravis after Extended Thymectomy
por: Lu, Chang-Feng, et al.
Publicado: (2018)

A case of thymoma in myasthenia gravis: Successful outcome after thymectomy()
por: Dahal, S., et al.
Publicado: (2019)

Review Analysis on Thymectomy vs Conservative Medical Management in Myasthenia Gravis
por: Rashid, Muhammad Humayoun, et al.
Publicado: (2020)

Thymolipomatous myasthenia gravis outcomes following thymectomy: a systematic review
por: Alghamdi, Zeead M, et al.
Publicado: (2021)

Perioperative challenges and neuromuscular blockade concerns in robotic thymectomy for myasthenia gravis
por: Pal, Atish, et al.
Publicado: (2020)

Neuropsychiatric lupus erythematosus with neurogenic pulmonary edema and anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor limbic encephalitis: a case report
por: Li, Rongqi, et al.
Publicado: (2022)

Risk factors of myasthenia crisis after thymectomy among myasthenia gravis patients: A meta-analysis
por: Geng, Yingcai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qe9aeskbfd3dt7cl079t0ena3u